Search

Research has shown that quitting tobacco use immediately improves health and that tobacco treatment programs make it easier to quit than going it alone.

… Thursday, October 3, 2024 Smoking cigarettes is known to cause at least 12 different types of cancer — not only  lung cancer and  head and neck cancers , but cancers of the  esophagus ,  pancreas ,  bladder ,  colon ,  rectum ,  cervix , and more. Research has shown that quitting tobacco use immediately

La investigación ha demostrado que dejar el consumo de tabaco mejora la salud de inmediato y que los programas de tratamiento del tabaquismo facilitan dejarlo más que intentarlo por su cuenta.

… Thursday, October 3, 2024 Se sabe que fumar cigarrillos causa al menos 12 tipos diferentes de cáncer, no solo  cáncer pulmonar y de  cabeza y cuello , sino también cáncer de  esófago ,  páncreas ,  vejiga ,  colon ,  recto ,  cuello uterino , entre otros. La investigación ha demostrado que dejar el consumo

Symantha Wilson was crushed when chemotherapy quit fighting her lymphoma — and thrilled when immuno¬therapy beat back the cancer. But why doesn’t immunotherapy help more people? MSK researchers are finding answers.

… Friday, April 1, 2022 Symantha Wilson knows she is one of the lucky ones. The 26-year-old Long Island resident was nearing the end of a six-month chemotherapy regimen for stage 2 Hodgkin lymphoma last June. The treatment had been very effective, wiping out most of the cancer cells. But with just over

More sugar available for immune cells could mean better immune responses against cancer.

… Monday, February 15, 2021 Summary New research from Memorial Sloan Kettering scientists suggests that a way to improve immunotherapy is by altering immune cells’ access to sugar. Cancer cells and immune cells share something in common: They both love sugar. Sugar is an important nutrient. All cells use

Like all researchers, nurse scientists design studies, accumulate data, and publish their findings. Their concentration in nursing means that they’re focused on patient needs, perspectives, and outcomes. Whereas a medical doctor might study how a drug is working, a nurse scientist may take a more holistic view of how a treatment affects a patient’s and their family’s quality of life.

… Friday, January 13, 2023 The mission for Kristen Fessele, PhD, RN, ANP-BC, AOCN, is personal. Her mother had survived cancer. But Dr. Fessele, a nurse scientist at Memorial Sloan Kettering Cancer Center (MSK), wanted to see her more than just survive — she wanted to see her thrive again. Dr. Fessele

Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who will benefit from immune checkpoint inhibitors using only routine blood tests and clinical data.

… Monday, January 6, 2025 Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors — a type of immunotherapy — using only routine blood tests and clinical data. The artificial intelligence–based

A generous gift provides a major boost to translational research at MSK.

… Friday, January 1, 2021 Dear MSK Community, Breakthrough cancer discovery can start anywhere: a patient with a unique case, a researcher with a hunch, or an unexpected result that connects seemingly disparate findings. An investigation into a new treatment can begin with the patient, move to the lab,

Physician-in-Chief Lisa M. DeAngelis joins healthcare experts during the AACR Virtual Meeting: COVID-19 and Cancer to discuss how to safely bring patients to the clinic so they can receive vital cancer screenings and care.

… Friday, July 17, 2020 Thousands of oncology experts from around the world will tune in virtually July 20-22 for the American Association for Cancer Research (AACR) Virtual Meeting: COVID-19 and Cancer . This special AACR conference will focus on emerging data in basic, clinical, and epidemiologic research

Scientists came to give talks and celebrate the achievements that the program has made under the leadership of Kathryn Anderson.

… Wednesday, November 21, 2018 A female scientist speaking Ruth Lehmann, Director of the Skirball Institute of Biomolecular Medicine at NYU Langone Health A male scientist speaking Siegfried Roth, a professor at the Institute for Zoology Biocenter at the University of Cologne, in Germany A female scientist

New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 ASCO Annual Meeting press program highlights a promising new treatment option for individuals previously treated for metastatic castration-resistant prostate cancer (mCRPC).

… Thursday, June 3, 2021 New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 ASCO Annual Meeting press program highlights a promising new treatment option for individuals previously treated for metastatic castration-resistant prostate cancer (mCRPC). The phase